KFG Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
KFG Wealth Management's IBB Position: Q3 2026 in Review
KFG Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 0.43% in Q3 2026, selling an estimated $3.61K and leaving 4,142 shares worth $872K. The position accounts for 0.09% of the portfolio, ranked #92.
KFG Wealth Management first reported a position in IBB in Q4 2022 and has held it in 11 quarters since. The position peaked at $8.99M in Q4 2022. 303 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- KFG Wealth Management held 4,142 shares of iShares Biotechnology ETF worth $872K as of Q3 2026.
- KFG Wealth Management sold 18 iShares Biotechnology ETF shares in Q3 2026, an estimated $3.61K.
- iShares Biotechnology ETF made up 0.09% of KFG Wealth Management's portfolio in Q3 2026, its #92 holding.
- KFG Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 11 quarters since.
- KFG Wealth Management's iShares Biotechnology ETF position peaked at $8.99M in Q4 2022.
- 303 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on KFG Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.